Nvidia’s Big Number

Nvidia’s Big Number

Up next

SpaceX’s $1 Trillion Revenue Ambition: Can Elon Musk Deliver?

Netflix is showing signs of maturity as growth slows, but is its valuation becoming attractive? SpaceX reported explosive revenue growth, and Elon Musk is projecting a staggering $1 trillion annual revenue run rate by the end of 2027. Travis Hoium, Lou Whiteman, and Jon Quast bre ...  Show more

GE & GM Earnings and Deals, Deals, Deals

Third quarter earnings reports are coming in fast, but this week kicks off with two Hidden Gem stocks making acquisitions to shore up their businesses. Lou, Matt, and Tyler discuss Salesforce's acquisition of Braze and Tradeweb Market’s Trumid acquisition. Plus, a mailbag about b ...  Show more

Recommended Episodes

Here comes the boom: Nvidia
Wall Street Breakfast

Nvidia's guidance could make or break the AI trade for the rest of '24. (0:18) Health check on the housing market. (3:34) First U.S. mpox case. (6:05) Show Notes Super Micro Computer to file plan on Monday to remain listed on Nasdaq Dividend Roundup Earnings Calendar Episode tran ...  Show more

The Deal Room: Is Nvidia's Magic Fading & Trump's Impact on the M&A Market for 2025
Market Maker

In this episode, Anthony Cheung and Stephen Barnett discuss Nvidia's recent earnings report, the implications of Trump's return on M&A activity, and the role of activist investors in corporate strategy. 


A great conversation connecting corporate finance theo ...

  Show more

Nvidia's big buildup, then a shrug
Wall Street Breakfast

Nvidia earnings - big buildup, then a shrug (0:54). Is big pharma out of favor? (3:40) How long can Bitcoin's run can last? (4:30) Target's disappointing report (6:15). Earnings season takeaways (8:20).

Episode transcripts: <a href="http://seekingalpha.com/wsb?source=w ...
  Show more

Nvidia Reports Results… And A Big Move In The Pharma Space 2/26/25
CNBC's "Fast Money"

Shares of Nvidia on the move after reporting its latest results. How the Fast Money traders are handling the semi giant, and the impact it has on the broader market. Plus Madrigal Pharma surging on the back of results. The latest drug data pushing that name higher, and what th ...

  Show more